Glenview Capital, a prominent activist investor, has reduced its investment in CVS Health following its robust first-quarter performance. The hedge fund noted a 25% return since initiating its stake last year, reflecting company recovery progress.
3 replies (most recent on top)
Old Aetna person here. I laughed when I saw Karen become your CEO. I still laugh out loud when I think about it. LOL,LOL
But but she was voted Healthcare CEO of the year!….
Congrats to Glenview for figuring out what a lot of us did a long time ago - getting rid of Karen alone would bump the stock price up.